NYSE:WAT

Waters Corp (WAT)

376.89
+7.71 (2.09%)
as of Jun 25, 2026, 8:00:00 pm Market Open.
6 watching
0
Investor Insights
star iconJun 25, 2026, 12:00 am

This summary was created by AI, based on 2 opinions in the last 12 months.

Waters Corp (WAT-N) experienced fluctuations in its stock performance this year, particularly following the acquisition of part of Becton Dickinson's (BDX) biosciences and diagnostic solutions business. Despite initial market skepticism that led to a significant drop in share price, the company has demonstrated resilience, with shares rebounding by 45% recently. The latest quarterly report showed promising results, including an 8% increase in revenue and improved earnings, coupled with a favorable full-year forecast. The market reaction to the $17.5 billion acquisition was mixed, with some experts believing the decline of 13.81% was an overreaction, particularly noting the advantages for BDX in the deal regarding shares and debt management.

consensus icon
Consensus
Positive
valuation icon
Valuation
Fair Value
review icon
Similar
BDX,BDX
BUY

The stock was doing well into early this year when they combined Becton Dickinson's biosciences & diagnostic solutions business last July. Shares plunged, which he didn't understand, but have since turned around, up 45%. They reported a great quarter last month with revenue up 8% and earnings up as well as its full-year forecast.

COMMENT

It will buy part of BDX for $17.5 billion. The market reacted badly, pushing WAT shares by 13.81% which is too much. It was a good deal for BDX, because of the shares received and the debt paid off.

PARTIAL BUY

Life sciences suffered post-Covid after rallying during Covid. WAT is a major player. Last Wednesday they reperted a clean top/bottom line beat, but issued a cautious earnings forecast, so the market gave a muted reaction. Likes them, because they have few competitors at at time when the economy is slowing down.

BUY
After years of stagnation, WAT brought in a new CEO in Sept. 2020. It nearly doubled in the next 12 months, then pulled back a lot. WAT assists drug and biotech companies, businesses he likes that are putting up excellent quarters.
DON'T BUY

WAT vs. TMO vs. DHR Not performing as well as Thermo Fisher or Danaher. Cash from operations has been flat in the last 4 years, whereas the other two have doubled, which is reflected in the stock price. Market share, operating margins, and pricing power impact the business model. Compare these when assessing competitors in an industry.

Showing 1 to 5 of 5 entries
  • «
  • 1
  • »

Waters Corp (WAT) Frequently Asked Questions

What is Waters Corp stock symbol?

Waters Corp is a American stock, trading under the symbol WAT (previously WAT-N on Stockchase) on the New York Stock Exchange (WAT). It is usually referred to as NYSE:WAT or WAT

Is Waters Corp a buy or a sell?

In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on WAT (previously WAT-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for Waters Corp.

Is Waters Corp a good investment or a top pick?

Waters Corp was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Waters Corp.

Why is Waters Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Waters Corp.

Is Waters Corp worth watching?

Waters Corp is followed by 6 investors on Stockchase and is a trending stock that is worth watching.

What is Waters Corp stock price?

On 2026-06-25, Waters Corp (WAT) stock closed at a price of $376.89.